NCT06537414 A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06497504 Study of Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection (B-Focus) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06422767 Study to Evaluate the Effect of Bepirovirsen on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT05630820 Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2) Status COMPLETED Phase PHASE3
NCT05630807 Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 1) Status COMPLETED Phase PHASE3
NCT05330455 Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection Status TERMINATED Phase PHASE1/PHASE2
NCT04954859 Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure) Status ACTIVE_NOT_RECRUITING Phase PHASE2